Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Maintenance Treatment for Relapse Prevention in Schizophrenia

NCT00848432 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.

NCT NCT00848432
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Maintenance Treatment for Relapse Prevention in Schizophrenia
Lead sponsor
Capital Medical University
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2002
Completion date
December 31, 2004
Enrollment
404 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia